PERK silence inhibits glioma cell growth under low glucose stress by blockage of p-AKT and subsequent HK2′s mitochondria translocation

被引:61
作者
Hou, Xu [1 ]
Liu, Yaohua [1 ]
Liu, Huailei [1 ]
Chen, Xin [1 ]
Liu, Min [2 ]
Che, Hui [3 ]
Guo, Fei [3 ]
Wang, Chunlei [1 ]
Zhang, Daming [1 ]
Wu, Jianing [1 ]
Chen, Xiaofeng [1 ]
Shen, Chen [1 ]
Li, Chenguang [1 ]
Peng, Fei [1 ]
Bi, Yunke [1 ]
Yang, Zhuowen [4 ]
Yang, Guang [1 ]
Ai, Jing [3 ]
Gao, Xin [5 ]
Zhao, Shiguang [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 1, Dept Neurosurg, Harbin, Heilongjiang Pr, Peoples R China
[2] Beijing Univ Chinese Med, Coll Basic Med, Beijing, Peoples R China
[3] Harbin Med Univ, State Prov Key Labs Biomed Pharmaceut China, Dept Pharmacol, Harbin, Heilongjiang Pr, Peoples R China
[4] Harbin Med Univ, Affiliated Hosp 1, Dept Endocrinol, Harbin, Heilongjiang Pr, Peoples R China
[5] KAUST, Comp Elect & Math Sci & Engn Div, Thuwal, Saudi Arabia
基金
中国国家自然科学基金;
关键词
ENDOPLASMIC-RETICULUM STRESS; GLIOBLASTOMA CELLS; APOPTOSIS; PATHWAY; CANCER; HYPOXIA; ACTIVATION; AUTOPHAGY; ATTENUATION; GLYCOLYSIS;
D O I
10.1038/srep09065
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Glioma relies on glycolysis to obtain energy and sustain its survival under low glucose microenvironment in vivo. The mechanisms on glioma cell glycolysis regulation are still unclear. Signaling mediated by Double-stranded RNA-activated protein kinase (PKR) - like ER kinase (PERK) is one of the important pathways of unfolded protein response (UPR) which is comprehensively activated in cancer cells upon the hypoxic and low glucose stress. Here we show that PERK is significantly activated in human glioma tissues. PERK silencing results in decreased glioma cell viability and ATP/lactate production upon low glucose stress, which is mediated by partially blocked AKT activation and subsequent inhibition of Hexokinase II (HK2)'s mitochondria translocation. More importantly, PERK silenced glioma cells show decreased tumor formation capacity. Our results reveal that PERK activation is involved in glioma glycolysis regulation and may be a potential molecular target for glioma treatment.
引用
收藏
页数:9
相关论文
共 39 条
[1]   Rapamycin-mediated mTOR inhibition attenuates survivin and sensitizes glioblastoma cells to radiation therapy [J].
Anandharaj, Arunkumar ;
Cinghu, Senthilkumar ;
Park, Woo-Yoon .
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2011, 43 (04) :292-300
[2]   Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity [J].
Atkins, Charity ;
Liu, Qi ;
Minthorn, Elisabeth ;
Zhang, Shu-Yun ;
Figueroa, David J. ;
Moss, Katherine ;
Stanley, Thomas B. ;
Sanders, Brent ;
Goetz, Aaron ;
Gaul, Nathan ;
Choudhry, Anthony E. ;
Alsaid, Hasan ;
Jucker, Beat M. ;
Axten, Jeffrey M. ;
Kumar, Rakesh .
CANCER RESEARCH, 2013, 73 (06) :1993-2002
[3]   Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK [J].
Avivar-Valderas, A. ;
Bobrovnikova-Marjon, E. ;
Diehl, J. Alan ;
Bardeesy, N. ;
Debnath, J. ;
Aguirre-Ghiso, J. A. .
ONCOGENE, 2013, 32 (41) :4932-4940
[4]   Modulation of the Akt Pathway Reveals a Novel Link with PERK/eIF2α, which Is Relevant during Hypoxia [J].
Blaustein, Matias ;
Perez-Munizaga, Daniela ;
Alejandro Sanchez, Manuel ;
Urrutia, Carolina ;
Grande, Alicia ;
Risso, Guillermo ;
Srebrow, Anabella ;
Alfaro, Jennifer ;
Colman-Lerner, Alejandro .
PLOS ONE, 2013, 8 (07)
[5]   PERK Utilizes Intrinsic Lipid Kinase Activity To Generate Phosphatidic Acid, Mediate Akt Activation, and Promote Adipocyte Differentiation [J].
Bobrovnikova-Marjon, Ekaterina ;
Pytel, Dariusz ;
Riese, Matthew J. ;
Vaites, Laura Pontano ;
Singh, Nickpreet ;
Koretzky, Gary A. ;
Witze, Eric S. ;
Diehl, J. Alan .
MOLECULAR AND CELLULAR BIOLOGY, 2012, 32 (12) :2268-2278
[6]   Akt signaling pathway: a target for radiosensitizing human malignant glioma [J].
Chautard, Emmanuel ;
Loubeau, Gaelle ;
Tchirkov, Andrei ;
Chassagne, Jacques ;
Vermot-Desroches, Claudine ;
Morel, Laurent ;
Verrelle, Pierre .
NEURO-ONCOLOGY, 2010, 12 (05) :434-443
[7]   Inhibition of Akt Potentiates 2-DG-Induced Apoptosis via Downregulation of UPR in Acute Lymphoblastic Leukemia [J].
DeSalvo, Joanna ;
Kuznetsov, Jeffim N. ;
Du, Jianfeng ;
Leclerc, Gilles M. ;
Leclerc, Guy J. ;
Lampidis, Theodore J. ;
Barredo, Julio C. .
MOLECULAR CANCER RESEARCH, 2012, 10 (07) :969-978
[8]   PERK-ing up autophagy during MYC-induced tumorigenesis [J].
Dey, Souvik ;
Tameire, Feven ;
Koumenis, Constantinos .
AUTOPHAGY, 2013, 9 (04) :612-614
[9]   Synthetic lethal metabolic targeting of cellular senescence in cancer therapy [J].
Doerr, Jan R. ;
Yu, Yong ;
Milanovic, Maja ;
Beuster, Gregor ;
Zasada, Christin ;
Daebritz, J. Henry M. ;
Lisec, Jan ;
Lenze, Dido ;
Gerhardt, Anne ;
Schleicher, Katharina ;
Kratzat, Susanne ;
Purfuerst, Bettina ;
Walenta, Stefan ;
Mueller-Klieser, Wolfgang ;
Graeler, Markus ;
Hummel, Michael ;
Keller, Ulrich ;
Buck, Andreas K. ;
Doerken, Bernd ;
Willmitzer, Lothar ;
Reimann, Maurice ;
Kempa, Stefan ;
Lee, Soyoung ;
Schmitt, Clemens A. .
NATURE, 2013, 501 (7467) :421-+
[10]   Hallmarks of Cancer: The Next Generation [J].
Hanahan, Douglas ;
Weinberg, Robert A. .
CELL, 2011, 144 (05) :646-674